89bio earnings were -$367.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ETNB earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$118.4M, down 20.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ETNB reported annual earnings of -$367.1M, with 158.2% growth. The next ETNB earnings date is May 7, 2025.
On ETNB's earnings call on Invalid Date, 89bio (NASDAQ: ETNB) reported Q4 2024 earnings per share (EPS) of -$1.05, up 110% year over year. Total ETNB earnings for the quarter were -$118.35 million. In the same quarter last year, 89bio's earnings per share (EPS) was -$0.50.
The next ETNB earnings date is Invalid Date. Add ETNB to your watchlist to be reminded of 89bio's next earnings date.
What was ETNB's earnings growth in the past year?
As of 89bio's earnings date in Invalid Date, 89bio's earnings has grown year over year. ETNB earnings in the past year totalled -$367.08 million.
Is 89bio profitable or losing money?
As of the last 89bio earnings report, 89bio is currently losing money. 89bio's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$367.08 million, a 158.16% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.